Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 36.10B | 32.69B | 34.22B | 33.63B | 36.41B | 39.91B |
Gross Profit | 35.65B | 0.00 | 33.95B | 33.63B | 36.41B | 39.91B |
EBITDA | -15.49B | 2.67B | -22.02B | -3.62B | 5.63B | 0.00 |
Net Income | -23.86B | 1.56B | -23.46B | -7.08B | 2.58B | -3.18B |
Balance Sheet | ||||||
Total Assets | 2.69T | 2.48T | 2.68T | 2.66T | 2.70T | 2.66T |
Cash, Cash Equivalents and Short-Term Investments | 236.38B | 0.00 | 358.62B | 222.27B | 224.83B | 203.94B |
Total Debt | 108.97B | 82.93B | 128.76B | 68.92B | 82.99B | 50.90B |
Total Liabilities | 108.97B | 2.39T | 2.60T | 68.92B | 2.60T | 2.55T |
Stockholders Equity | 99.66B | 82.47B | 83.39B | 77.50B | 100.67B | 116.20B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 29.99B | -8.08B | -21.38B | 27.98B | 95.03B |
Operating Cash Flow | 0.00 | 30.42B | -5.35B | -19.97B | 28.96B | 96.88B |
Investing Cash Flow | 0.00 | -6.87B | 129.91B | 19.55B | -7.98B | -84.95B |
Financing Cash Flow | 0.00 | -213.89B | 19.64B | -656.00M | -698.00M | 2.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥66.43B | 5.00 | 3.64% | 21.73% | 151.58% | ||
74 Outperform | $336.03B | 10.91 | 4.21% | 3.13% | 5.52% | 15.05% | |
74 Outperform | $5.75T | 14.04 | 4.38% | 3.60% | -15.25% | 16.43% | |
71 Outperform | ¥1.23T | 10.58 | 3.05% | 26.21% | 41.82% | ||
68 Neutral | ¥724.27B | 10.74 | 7.55% | 3.29% | 7.97% | 15.90% | |
60 Neutral | ¥1.08T | 13.21 | 6.37% | 3.38% | 8.79% | 19.19% | |
41 Neutral | ¥9.23B | 5.93 | 1.45% | 2.89% | -993.38% |